CLL cells drive these T-cell abnormal phenotypes by releasing factors such as IL-10 and TGF-β1, which impair T-cell activation and effector functions, ultimately facilitating CLL cell survival and proliferation [88]. The gene discussed is IL10; the disease is B-cell chronic lymphocytic leukemia.